Medication adherence among the older adults: challenges and recommendations by Huang, Junjie et al.
476 Hong Kong Medical Journal    ©2020 Hong Kong Academy of Medicine. CC BY-NC-ND 4.0
Junjie Huang1, MD, MSc, Harry HX Wang1, PhD, Zhijie Zheng2,3, MD, PhD, Martin CS Wong4,5, MD, MPH
1 Editor, Hong Kong Medical Journal
2 International Editorial Advisory Board, Hong Kong Medical Journal
3 Department of Global Health, School of Public Health, Peking University, Beijing, China
4 Editor-in-Chief, Hong Kong Medical Journal
5 The Jockey Club School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong
* Corresponding author: junjie_huang@link.cuhk.edu.hk
Medication adherence among the older adults: 
challenges and recommendations
Growing burden of the ageing 
populations
There is an increasing burden of the elderly 
population in many countries, with an estimated total 
of 2.37 billion population aged >65 years globally by 
2100.1 In Hong Kong, the number of people aged 
>65 years is expected to increase from 1.19 million 
to 2.51 million from 2016 to 2046, then comprising 
more than one third of the total population.2 The 
substantial increase in the elderly population will 
inevitably contribute to the burden of public health 
and healthcare service, with chronic diseases and 
multimorbidity being the critical challenges.
Chronic diseases associated with 
ageing populations
The leading causes of morbidity and mortality in the 
elderly population are chronic diseases. More than 
70% of the population aged ≥60 years have one or more 
chronic diseases in Hong Kong, with hypertension, 
arthritis, and eye diseases being the most frequent 
morbidities.3 The major causes of mortality among 
the elderly population include cancer, heart diseases, 
cerebrovascular disease, and pneumonia. Moreover, 
dementia is also very common: local data indicate 
that almost 1 in 10 community-dwelling elderly 
individuals have mild cognitive impairment (8.5%) 
or mild dementia (8.9%) in Hong Kong.4
Multimorbidity associated with 
ageing populations
Multimorbidity is commonly defined as the presence 
of two or more chronic conditions. Its prevalence has 
been increasing over the past decade primarily due 
to the ageing population and westernised lifestyles.5 
A cross-sectional community-based study in Hong 
Kong found that 42% of individuals aged ≥60 years 
had multimorbidity.6 Multimorbidity poses a heavy 
clinical and public health burden by increasing 
healthcare cost and utilisation. Considering most 
healthcare systems globally are developed to treat 
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single disease, multimorbidity leads to major 
challenges for healthcare providers.
Importance of medication 
adherence among elderly 
individuals
Elderly patients with chronic diseases and 
multimorbidity have a higher risk of polypharmacy 
and suboptimal medication adherence. In general, 
adherence rates are lower among elderly individuals 
with chronic conditions than those with acute 
diseases, and the rates may differ among disease 
categories. According to a survey conducted by the 
World Health Organization, approximately 40% of 
older patients with chronic conditions do not follow 
their planned prescriptions.7 Polypharmacy, which 
is often defined as the concurrent prescription 
of five or more drugs, is commonly seen among 
elderly patients with multimorbidity. Approximately 
two thirds of community-dwelling older patients 
have polypharmacy.8 A substantial proportion 
of patients with polypharmacy take 10 or more 
different types of drugs (“hyperpolypharmacy”). 
Polypharmacy is more closely related to suboptimal 
medication adherence than other reasons, such 
as adverse drug reactions (ADRs), inappropriate 
medication, or pharmacological interactions.9 As 
a result, the high prevalence of polypharmacy and 
hyperpolypharmacy subsequently increased the risk 
of suboptimal medication adherence among elderly 
individuals. This situation could be even worse in 
elderly patients with decreased functionality, in 
particular among those with cognitive impairment 
and dementia.10-13
 In this issue of the Hong Kong Medical Journal, 
Wong14 reviewed the medication-related problems 
among the older population, including medication 
non-adherence. The results show that the elderly 
patients are at higher risk of medication-related 
issues due to the physiological changes with ageing 
and multiple medications used for multimorbidity. 
Polypharmacy is associated with inappropriate 
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drug use which may in turn leads to multiple 
geriatric syndromes and hospitalisation. Also, either 
intentional or unintentional suboptimal medication 
compliance can lead to treatment failure. The article 
points out that a substantial proportion of ADRs are 
preventable, and that effective strategies are available 
to tackle these issues to achieve good medication 
adherence and drug safety. The strategies included 
deprescribing with the withdrawal of drugs that are 
considered of minimum, using a patient-centred 
approach which considers patient preferences 
when determining the treatment goal, and adopting 
a multidisciplinary approach in medication 
management.
 Medication adherence measures the extent 
to which individual’s medication taking behaviour 
complies with the planned prescriptions from 
physicians. A patient taking a proportion of 80% to 
120% for prescribed drugs over a certain period is 
generally considered as an adherent to medications.7 
Medication adherence is crucial and essential as 
it has a substantial impact on the effectiveness of 
medications and control of chronic conditions. The 
World Health Organization has used “adherence 
enhancing” as an important strategy to effectively 
tackle chronic conditions.15 By contrast, medications 
non-adherence is a phenomenon where the individual 
does not adhere to the prescribed medications by 
healthcare providers, including under-utilisation, 
over-utilisation, and incorrect utilisation. There 
are several ways to measure medication adherence, 
including completing self-reported questionnaires 
(eg, Brief Medication Questionnaire16), counting 
pills, or measuring drug or metabolite levels through 
a blood test.
 Suboptimal medication adherence can result 
from intentional and unintentional factors.17 
Intentional non-adherence is caused by patients who 
simply do not follow the prescribed instructions or 
intentionally stop taking a medication. Unintentional 
non-adherence may be caused by forgetfulness or 
limited knowledge of the diseases or prescribed 
medications, or by physical, psychological, or mental 
barriers. Physicians may have inadequate time to 
discuss with patients on the medication adherence 
during clinical encounters. Factors for medication 
non-adherence that are commonly reported include 
complexity of medications, presence of ADRs, 
frequent changes to prescriptions, and limited family 
or social support.
 The major health consequences of suboptimal 
medication compliance among elderly patients 
include poor medication response, decreased 
treatment safety, and impaired life quality.7 Other 
consequences increased number of emergency visits, 
duration of hospitalisations, morbidity, mortality, 
and healthcare costs. A substantial proportion of 
preventable ADRs are attributable to suboptimal 
medication adherence among elderly patients. For 
instance, 33% to 69% of drug-related hospitalisations 
are caused by poor medication adherence in 
the United States, which induces an avoidable 
annual healthcare cost of US$100 to 300 billion.18 
Suboptimal medication adherence among patients is 
also a source of frustration and job dissatisfaction for 
healthcare providers.
Recommendations
Different strategies to enhance medication 
adherence among the elderly patients have been 
investigated. Most strategies aim to modify personal 
health behaviours by delivering counselling, 
reminders, education, or a combination of these 
approaches. These approaches can be generally 
divided into political, organisational, behavioural, 
and educational interventions, with different focuses 
on policy, system and environmental, and patient 
and their family levels.19
Policy level
Political interventions mainly focus on allocating 
more resources for enhancing medication adherence 
to different related sectors, including education, 
healthcare cost, and health regulations.20 It is 
important to raise public awareness and knowledge 
on suboptimal medication adherence among elderly 
patients. Another typical approach to enhancing 
medication adherence among elderly patients is to 
reduce their out-of-pocket expenses for medication 
prescriptions. Relevant regulations can also be 
developed to ensure that healthcare professionals 
have sufficient attention for the issue of medication 
adherence among patients.
System and environmental level
Organisational interventions aim to reduce 
barriers to medication adherence by pharmacy 
refills and adherence reminders comprehensively 
and systematically. This is often carried out by 
a multidisciplinary team involving physicians, 
pharmacists, psychologists, and community care 
givers.21,22 It is important for physicians to enhance 
communication by listening to patients more 
about their concerns to determine a compromised 
medication plan.23 Regular assessment and 
simplification of treatment prescription by 
pharmacists is needed. Elderly patients who had 
suspected psychological problems such as depression 
should be assessed by psychologists for medication 
management. Community caregivers are also 
helpful in medication management for the elderly 
patients with less family support.24 Behavioural 
interventions modify the environmental factors to 
facilitate medication use with instruments among 
the elderly patients. These interventions include 
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instruments such as alarm clocks, reminder lists, or 
advanced pillboxes, as well as group social support, 
surveillance feedback system, and follow-up visits. 
Mobile health (mHealth) interventions, such as 
smartphone applications, can also be innovative 
and promising means to assist in the management 
of medication adherence for elderly patients with 
chronic diseases.
Patient and their family level
Educational interventions, either based on group or 
individual learning from healthcare professionals, 
are useful for promoting medication adherence 
among elderly patients.25 They provide elderly 
patients or their caregivers with better knowledge 
of their health conditions, prescriptions, ADRs, 
and the importance of compliance to facilitate 
the informed decision makings. It is also useful to 
encourage elderly patients to be actively involved 
in the disease management process, for instance, 
self-monitoring of blood glucose, blood pressure, 
and blood lipids. Family members are encouraged 
to assist in medication management, especially for 
elderly people with decreased functionality, mood 
disorders, or cognitive impairment.
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